| Canadian Enterprises Gallery | |
 Canadian Heritage
GalleryCanadian
Enterprises Gallery |
Baxter
Corporation
First incorporated in 1937 as Baxter Laboratories of Canada, the company began with seven people producing intravenous solutions in a rented building in Toronto. Today, the company employs more than eight hundred people across Canada. The Canadian headquarters are in Mississauga, Ontario, with regional offices in Burnaby, British Columbia, and Pointe Claire, Quebec. Award-winning manufacturing facilities are located in Alliston, Ontario and Sherbrooke, Quebec. The global headquarters for Baxter International are located in Deerfield, Illinois. www.Baxter.com The success of this company can be traced to its market leadership and manufacturing excellence within three core businesses: Renal Therapy, Medication Delivery, and BioSciences. Market Leadership In 1939, the company introduced the first sterile
vacuum-type blood collection container, making blood-banking practical for
the first time. In 1956, Baxter
Manufacturing Excellence Baxter Corporation prides itself on its
manufacturing excellence. The Baxter plant in
Alliston, Ontario, won the
National Quality Institute’s Canada Award for Excellence, Large
Manufacturing in 1996. Baxter is the f Underlying the company’s expertise is passion…the passion to advance the frontiers of medicine. The passion to bring life-saving therapies to patients. The passion to listen to its customers, and bring them solutions to the challenges they face everyday. The company can be reached at: Telephone: |
| Copyright © 2001 Canadian Heritage Gallery | |
introduced the first commercially built
artificial kidney machine, making life-saving dialysis therapy a reality
for people suffering from kidney disease. Then in 1966, Baxter introduced
the first commercially produced Factor VIII concentrate to treat
hemophilia. In 1970, the Alliston plant became the first facility in the
world to manufacture a plastic container for IV solutions, eliminating the
safety concerns with respect to glass containers. Other "firsts"
over the years have included the introduction of continuous ambulatory
peritoneal dialysis as an alternative to hemodialysis, the first "needleless"
system for IV therapy to protect health-care workers from needle-stick
accidents and the first automated blood-cell separator, setting a new
standard for the collection of cellular blood components.
With the company investing a million dollars per day
in research and development, they are investing in the future. A future
that includes Baxter researchers working to enhance
the safety of the blood supply with technologies to inactivate pathogens
in collected blood components. A future that includes genetically
engineering animal organs for transplant into humans. A future that
includes new genetically engineered hemoglobin therapeutics and improved
vaccines for the prevention of a variety of infectious diseases.
irst company in the health care
sector to ever win this award. In 1997, the Sherbrooke facility was
honoured to receive the "Qualimètre" Award. In 1998, the
Sherbrooke plant was named "Plant of the Year" by the Maison
Régionale de l’Industrie and won the prestigious "Grand Prix
québécois de la qualité" in 1999.